Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ALSUntangled #64: butyrates.
Sun Y, Bedlack R, Armon C, Beauchamp M, Bertorini T, Bowser R, Bromberg M, Caress J, Carter G, Crayle J, Cudkowicz ME, Glass JD, Jackson C, Lund I, Martin S, Paganoni S, Pattee G, Ratner D, Salmon K, Wicks P. Sun Y, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):638-643. doi: 10.1080/21678421.2022.2045323. Epub 2022 Feb 28. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 35225121 Review.
"ALS reversals": demographics, disease characteristics, treatments, and co-morbidities.
Harrison D, Mehta P, van Es MA, Stommel E, Drory VE, Nefussy B, van den Berg LH, Crayle J, Bedlack R; Pooled Resource Open-Access ALS Clinical Trials Consortium. Harrison D, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):495-499. doi: 10.1080/21678421.2018.1457059. Epub 2018 Apr 2. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29607695
Total serum immunoglobulin A in ALS.
Crayle J, Elmallah M, Sleasman J, Bedlack R. Crayle J, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Feb;22(1-2):61-65. doi: 10.1080/21678421.2020.1790608. Epub 2020 Jul 16. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 32672072
ALSUntangled 59: Tamoxifen.
Bedlack R, Kihuwa-Mani S, Barkhaus PE, Bereman M, Caress JB, Crayle J, Pattee GL, Heiman Patterson T, Wicks P, Zach N, Carter GT, Salmon K. Bedlack R, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):595-598. doi: 10.1080/21678421.2021.1876731. Epub 2021 Jan 21. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 33474997
ALSUntangled #60: light therapy.
Bedlack R, Barkhaus P, Barnes B, Bereman M, Bertorini T, Carter G, Crayle J, Kihuwa-Mani S, Bowser R, Kittrell P, McDermott C, Pattee G, Salmon K, Wicks P. Bedlack R, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2022 May;23(3-4):315-319. doi: 10.1080/21678421.2021.1883668. Epub 2021 Mar 8. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 33683159 Review.
ALSUntangled #62: vitamin C.
Bedlack R, Barkhaus P, Carter G, Crayle J, Mcdermott C, Pattee G, Polak M, Salmon K, Wicks P. Bedlack R, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug;23(5-6):476-479. doi: 10.1080/21678421.2021.1946088. Epub 2021 Jun 30. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 34187257
Study of "ALS reversals": LifeTime environmental exposures (StARLiTE).
Crayle J, Lutz M, Raymond J, Mehta P, Bedlack R. Crayle J, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):54-62. doi: 10.1080/21678421.2022.2090846. Epub 2022 Jul 1. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35775279
ALSUntangled #65: glucocorticoid corticosteroids.
Goslinga JA, Terrelonge M Jr, Bedlack R, Barkhaus P, Barnes B, Bertorini T, Bromberg M, Carter G, Chen A, Crayle J, Dimachkie M, Jiang L, Levitsky G, Lund I, Martin S, Mcdermott C, Pattee G, Pierce K, Ratner D, Slachtova L, Sun Y, Wicks P. Goslinga JA, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2023 May;24(3-4):351-357. doi: 10.1080/21678421.2022.2099746. Epub 2022 Aug 23. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35997522 Review.
ALSUntangled #67: rituximab.
Li X, Armon C, Barkhaus P, Barnes B, Benatar M, Bertorini T, Bromberg M, Carter GT, Crayle J, Cudkowicz M, Dimachkie M, Feldman EL, Glass J, Goslinga J, Heiman-Patterson T, Jhooty S, Lichtenstein R, Lund I, Mcdermott C, Pattee G, Pierce K, Ratner D, Salmon K, Wicks P, Bedlack R. Li X, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5-6):544-547. doi: 10.1080/21678421.2022.2122845. Epub 2022 Sep 15. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36106861 Review.
ALSUntangled #68: ozone therapy.
Sun Y, Barkhaus P, Barnes B, Beauchamp M, Benatar M, Bertorini T, Bromberg M, Carter GT, Crayle J, Cudkowicz M, Dimachkie M, Feldman EL, Fullam T, Heiman-Patterson T, Jhooty S, Lund I, Mcdermott C, Pattee G, Pierce K, Ratner D, Wicks P, Bedlack R. Sun Y, et al. Among authors: crayle j. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5-6):548-552. doi: 10.1080/21678421.2022.2145904. Epub 2022 Nov 18. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36398749 Review.
16 results